Profound Medical (TSE:PRN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Profound Medical has partnered with Siemens Healthineers to offer an innovative MRI-guided prostate therapy combining Profound’s TULSA-PRO system with Siemens’ Magnetom Free.Max scanner. This collaboration aims to enhance the precision and accessibility of prostate treatments, benefiting patients with various prostate conditions.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.